Skip to main content
The Globe and Mail
Support Quality Journalism
The Globe and Mail
First Access to Latest
Investment News
Collection of curated
e-books and guides
Inform your decisions via
Globe Investor Tools
Just$1.99
per week
for first 24 weeks

Enjoy unlimited digital access
Enjoy Unlimited Digital Access
Get full access to globeandmail.com
Just $1.99 per week for the first 24 weeks
Just $1.99 per week for the first 24 weeks
var select={root:".js-sub-pencil",control:".js-sub-pencil-control",open:"o-sub-pencil--open",closed:"o-sub-pencil--closed"},dom={},allowExpand=!0;function pencilInit(o){var e=arguments.length>1&&void 0!==arguments[1]&&arguments[1];select.root=o,dom.root=document.querySelector(select.root),dom.root&&(dom.control=document.querySelector(select.control),dom.control.addEventListener("click",onToggleClicked),setPanelState(e),window.addEventListener("scroll",onWindowScroll),dom.root.removeAttribute("hidden"))}function isPanelOpen(){return dom.root.classList.contains(select.open)}function setPanelState(o){dom.root.classList[o?"add":"remove"](select.open),dom.root.classList[o?"remove":"add"](select.closed),dom.control.setAttribute("aria-expanded",o)}function onToggleClicked(){var l=!isPanelOpen();setPanelState(l)}function onWindowScroll(){window.requestAnimationFrame(function() {var l=isPanelOpen(),n=0===(document.body.scrollTop||document.documentElement.scrollTop);n||l||!allowExpand?n&&l&&(allowExpand=!0,setPanelState(!1)):(allowExpand=!1,setPanelState(!0))});}pencilInit(".js-sub-pencil",!1); // via darwin-bg var slideIndex = 0; carousel(); function carousel() { var i; var x = document.getElementsByClassName("subs_valueprop"); for (i = 0; i < x.length; i++) { x[i].style.display = "none"; } slideIndex++; if (slideIndex> x.length) { slideIndex = 1; } x[slideIndex - 1].style.display = "block"; setTimeout(carousel, 2500); }
HIGHLIGHTS
  1. HelloMD to give medical cannabis advice for Shoppers Drug Mart
  2. Delta 9 sees pharmacies integrating into medical pot distribution
  3. London Drugs positions pharmacy for medical cannabis foothold

HelloMD has partnered with Shoppers Drug Mart to give online patients access to medical cannabis advice, the California-based company said this week, the latest move within the Canadian pharmacy business that aims to increase revenue through pot sales.

Shoppers is the only pharmacy in Canada that has completed the lengthy licensing process and start selling medical marijuana online in Alberta and Ontario, but the industry is closely watching the opportunities this segment holds, with some licensed producers betting that drug stores will take on significant market share.

In April, licensed producer and retailer Delta 9 said it believes pharmacies will be integrated long-term into the distribution chain for medical cannabis products. The Manitoba-based company signed a non-binding letter of intent with Pharmasave Drugs to become a preferred supplier of medical pot, even as Delta 9 runs its own cannabis clinics.

Story continues below advertisement

London Drugs, which operates pharmacies in Canada’s four western provinces, is not licensed to sell medical marijuana but is positioning itself to build a foothold in the industry by training staff to educate and advise patients on aspects such as dosage and strains that can then be prescribed by doctors.

“A pharmacy can apply to sell medical cannabis under the medical sales licence category and that is how a pharmacy would be able to sell out of a central site direct to consumer. Pharmacies cannot sell out of their individual stores or send it there for patients to pick up. London Drugs is considering all options,” said Chris Chiew, general manager of Pharmacy for London Drugs.

“We continue to help patients through education and help guide patients through their medical cannabis therapeutic journey using our Medical Cannabis Educators. We also continue to advocate to the federal and provincial governments to allow pharmacies to dispense directly to patients as we do with all other drugs.”

One of Canada’s other big pharmacy companies, U.S.-owned Rexall, appears to be treading cautiously into future opportunities in medical cannabis.

“McKesson Canada and Rexall are committed to ensuring a secure and accessible supply chain for pharmaceutical products across the country. We have educated our pharmacists and staff on medical cannabis and have made available information and resources for patients,” said Darius Kuras, spokesperson for McKesson Canada.

The Ontario College of Pharmacists recently announced it will make cannabis education mandatory in pharmacies by March, 2020. The regulatory body in Canada’s biggest province said it opposes any smoked forms of medical cannabis being distributed by pharmacies, according to its website.

Report an error Editorial code of conduct
Due to technical reasons, we have temporarily removed commenting from our articles. We hope to have this fixed soon. Thank you for your patience. If you are looking to give feedback on our new site, please send it along to feedback@globeandmail.com. If you want to write a letter to the editor, please forward to letters@globeandmail.com.

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff. Non-subscribers can read and sort comments but will not be able to engage with them in any way. Click here to subscribe.

If you would like to write a letter to the editor, please forward it to letters@globeandmail.com. Readers can also interact with The Globe on Facebook and Twitter .

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff. Non-subscribers can read and sort comments but will not be able to engage with them in any way. Click here to subscribe.

If you would like to write a letter to the editor, please forward it to letters@globeandmail.com. Readers can also interact with The Globe on Facebook and Twitter .

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff.

We aim to create a safe and valuable space for discussion and debate. That means:

  • Treat others as you wish to be treated
  • Criticize ideas, not people
  • Stay on topic
  • Avoid the use of toxic and offensive language
  • Flag bad behaviour

Comments that violate our community guidelines will be removed.

Read our community guidelines here

Discussion loading ...

To view this site properly, enable cookies in your browser. Read our privacy policy to learn more.
How to enable cookies